← Leaderboards
Peter Goldman
Beth Israel Deaconess Medical Center
$805,098
Attributed
$805,098
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1K · FY2009–11$5K$3.8K$2.5K$1.3K$0
'09
'10
'11
Funding mix
By agency
NIH$805,098 · 4
By mechanism
R01$800,525 · 1
P41$4,573 · 3
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Sol Schulman$3,685,783
- David A Roth$2,143,870
- Barbara C Furie$9,637,605
- Bruce Furie$39,376,853
- John A.a. Ladias$3,950,340
Others in their field
Top investigators on “Anticoagulants”
- Walter N Kernan · Yale University$42,197,025
- John H Griffin · Scripps Research Institute$30,205,671
- Thomas L Ortel · Duke University$24,081,156
- Shunichi Homma · Columbia University Health Sciences$22,614,584
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$22,554,960
- Erik Ian Tucker · Aronora, Inc.$21,529,628
Research focus
AnticoagulantsDosageOxidative StressPlant ExtractsDrug Screening /EvaluationDrug InteractionsAlternative MedicineLaboratory RatWarfarinConiferaHuman TissueAntioxidantsCytochrome P450ApoptosisDna-Binding ProteinsFundingAnabolismGrantFormate C-AcetyltransferaseCell PhysiologyFormate Acetyltransferase Activating EnzymeFosfomycinEpoxidaseAntibiotics
Grant awards (8)
CRYSTALLOGRAPHIC STUDIES OF METALLOPROTEINS (NIKR, BIOB, PFLAE, AND HPPE)$279
P41 · FY2011 · RR · contact PI
CRYSTALLOGRAPHIC STUDIES OF METALLOPROTEINS (NIKR, BIOB, PFLAE, AND HPPE)$4,081
P41 · FY2010 · RR · contact PI
CRYSTALLOGRAPHIC STUDIES OF METALLOPROTEINS (NIKR, BIOB, PFLAE, AND HPPE)$213
P41 · FY2009 · RR · contact PI
Optimizing Therapeutic Ratios for Herbs$126,040
R01 · FY2004 · AT
Optimizing Therapeutic Ratios for Herbs$122,811
R01 · FY2003 · AT
Optimizing Therapeutic Ratios for Herbs$125,459
R01 · FY2002 · AT
Optimizing Therapeutic Ratios for Herbs$187,948
R01 · FY2001 · AT
Optimizing Therapeutic Ratios for Herbs$238,267
R01 · FY2000 · AT